Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase 3 Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared with Investigator's Choice Monotherapy Treatment in Previously Treated Patients with Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma

Disease Sites:

Not Available

Staging:

Phase III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Choe, Jennifer

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

02-21-2025

Trial Type:

Treatment

Protocol ID:

VICC-DTHAN23576

National Clinical Trial ID:

NCT06496178

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available